Efficacité et tolérance de deux formulations orales d'Augmentin® 1 g/125 mg deux fois par jour versus 500 mg/125 mg trois fois par jour dans les exacerbations aiguës de bronchite chronique. Étude multicentrique, comparative, randomisée, en double aveugle
- 31 October 2000
- journal article
- Published by Elsevier BV in Medecine Et Maladies Infectieuses
- Vol. 30 (10), 630-640
- https://doi.org/10.1016/s0399-077x(00)80034-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Peuton donner Augmentin*R oral en deux prises par jour?Medecine Et Maladies Infectieuses, 2000
- Efficacy of Oral Ciprofloxacin vs. Clarithromycin for Treatment of Acute Bacterial Exacerbations of Chronic BronchitisClinical Infectious Diseases, 1998
- Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A double-blind, randomised, parallel, multicentre studyJournal of Antimicrobial Chemotherapy, 1996
- Recommandations pour la prise en charge anti-infectieuse des exacerbations de bronchite chroniqueMedecine Et Maladies Infectieuses, 1996
- Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceEuropean Respiratory Journal, 1995
- Antibiotics in Chronic Obstructive Pulmonary Disease ExacerbationsJAMA, 1995
- Mortality in relation to smoking: 40 years' observations on male British doctorsBMJ, 1994
- Evaluation of New Anti-Infective Drugs for the Treatment of Respiratory Tract InfectionsClinical Infectious Diseases, 1992
- Bacterial Infection in Chronic Obstructive Pulmonary DiseaseAmerican Review of Respiratory Disease, 1992
- Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary DiseaseAnnals of Internal Medicine, 1987